Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 25, 2014 15:20 ET | Source: Arch Biopartners Inc.

Arch Biopartners Completes Private Placement

TORONTO, ONTARIO--(Marketwired - March 25, 2014) - Arch Biopartners Inc. ("Arch" or the "Company") (CNSX:ACH)(OTCBB:FOIFF) announced today it has raised $155,960 via a non-brokered...
March 12, 2014 16:50 ET | Source: Arch Biopartners Inc.

Arch Biopartners Announcement

TORONTO, ONTARIO--(Marketwired - March 12, 2014) - With profound sadness, Arch Biopartners Inc. announces the passing of its Chairman, Jerry McElroy. The Board and management will...
February 25, 2014 10:46 ET | Source: Arch Biopartners Inc.

Arch Biopartners Completes Private Placement and Receives NRC Funding

TORONTO, ONTARIO--(Marketwired - Feb. 25, 2014) - Arch Biopartners Inc ("Arch" or the "Company") (CSE:ACH)(OTCBB:FOIFF) announced today it has raised $228,900 via a non-brokered private...
February 25, 2014 08:55 ET | Source: Arch Biopartners Inc.

Arch Biopartners Completes Private Placement

TORONTO, ONTARIO--(Marketwired - Feb. 25, 2014) - Arch Biopartners Inc ("Arch" or the "Company") (CSE:ACH)(OTCBB:FOIFF) announced today it has raised $228,900 via a non-brokered private...
November 20, 2013 09:10 ET | Source: Arch Biopartners Inc.

Brain Tumor Cell Targeting Technology: Data to Be Presented at the Society of Neuro-Oncology Quadrennial Meeting

TORONTO, ONTARIO--(Marketwired - Nov. 20, 2013) - Arch Biopartners Inc (Arch) or (the Company) (CNSX:ACH)(OTCBB:FOIFF) announced today that data relating to proprietary technology...
October 21, 2013 07:00 ET | Source: Arch Biopartners Inc.

Arch Biopartners Announces Private Placement

TORONTO, ONTARIO--(Marketwired - Oct. 21, 2013) - Arch Biopartners Inc ("Arch" or the "Company")(CNSX:ACH)(OTCBB:FOIFF) is pleased to announce it has engaged M Partners Inc. (the "Agent")...
September 17, 2013 08:44 ET | Source: Arch Biopartners Inc.

Arch Biopartners Appoints Former Roche Executives Patrick Smith and Craig Rayner as Drug Development Advisors

TORONTO, ONARIO--(Marketwired - Sept. 17, 2013) - Arch Biopartners Inc (Arch) or (the Company) (CNSX:ACH)(OTCBB:FOIFF) announced today Dr. Patrick Smith and Dr. Craig Rayner of d3...
September 12, 2013 09:02 ET | Source: Arch Biopartners Inc.

Arch Biopartners Announces Issuance of U.S. Patent for Brain Tumor Cell Targeting Technology

TORONTO, ONTARIO--(Marketwired - Sept. 12, 2013) - Arch Biopartners Inc (Arch) or (the Company) (CNSX:ACH)(OTCBB:FOIFF) announced today that the U.S. Patent and Trademark Office has...
August 14, 2013 09:05 ET | Source: Arch Biopartners Inc.

Arch Biopartners Joins the Life Sciences Canadian Technology Accelerator in San Francisco

TORONTO, ONTARIO--(Marketwired - Aug. 14, 2013) - Arch Biopartners Inc (Arch) or (the Company)(CNSX:ACH) (OTCBB:FOIFF) announced today it has been accepted by the Consulate General of...
June 06, 2013 10:36 ET | Source: Arch Biopartners Inc.

Arch Biopartners Announces Issuance of Additional U.S. Patent for Biofilm Inhibitor

TORONTO, ONTARIO--(Marketwired - June 6, 2013) - Arch Biopartners Inc (Arch) or (the Company) (CNSX:ACH) (OTCBB:FOIFF) announced today that the U.S. Patent and Trademark Office has issued...